Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Slim

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
BMJ Open|May 9, 2022
Personalised immunotherapy in sepsis: a scoping review protocolMarleen A Slim, Niels van Mourik, Joanna C Dionne, et al.
Scientific Reports|April 20, 2024
The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patientsM A Slim, E H T Lim, L A van Vught, et al.
Critical Care (London, England)|May 28, 2024
Towards personalized medicine: a scoping review of immunotherapy in sepsisMarleen A Slim, Niels van Mourik, Lieke Bakkerus, et al.
Vaccine|September 29, 2023
25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinationsA H A Lavell, A E Schramade, J J Sikkens, et al.
Ebiomedicine|September 27, 2021
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccinationBrent Appelman, Karlijn van der Straten, A H Ayesha Lavell, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 21, 2007
Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective studyLuca S Belli, Andrew K Burroughs, Patrizia Burra, et al.
BMJ Open|January 5, 2023
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocolAntigone Kotsaki, Peter Pickkers, Michael Bauer, et al.
Intensive Care Medicine Experimental|August 18, 2025
A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patientsNiels van Mourik, Rombout B E van Amstel, Marleen A Slim, et al.
Iscience|September 6, 2023
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Tamas Pongracz, Tonći Šuštić, et al.
Plos Medicine|May 17, 2022
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort studyMarit J van Gils, Ayesha Lavell, Karlijn van der Straten, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
BMJ Open|May 9, 2022
Personalised immunotherapy in sepsis: a scoping review protocolMarleen A Slim, Niels van Mourik, Joanna C Dionne, et al.
Scientific Reports|April 20, 2024
The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patientsM A Slim, E H T Lim, L A van Vught, et al.
Critical Care (London, England)|May 28, 2024
Towards personalized medicine: a scoping review of immunotherapy in sepsisMarleen A Slim, Niels van Mourik, Lieke Bakkerus, et al.
Vaccine|September 29, 2023
25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinationsA H A Lavell, A E Schramade, J J Sikkens, et al.
Ebiomedicine|September 27, 2021
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccinationBrent Appelman, Karlijn van der Straten, A H Ayesha Lavell, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 21, 2007
Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective studyLuca S Belli, Andrew K Burroughs, Patrizia Burra, et al.
BMJ Open|January 5, 2023
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocolAntigone Kotsaki, Peter Pickkers, Michael Bauer, et al.
Intensive Care Medicine Experimental|August 18, 2025
A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patientsNiels van Mourik, Rombout B E van Amstel, Marleen A Slim, et al.
Iscience|September 6, 2023
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Tamas Pongracz, Tonći Šuštić, et al.
Plos Medicine|May 17, 2022
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort studyMarit J van Gils, Ayesha Lavell, Karlijn van der Straten, et al.
Pageof 9